Physician profile
Alejandro Mendoza
NPI 1003846494
$2,838.32
in general payments reported to CMS, 2019-2025
25 companies · $348 in 2025
The $348 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $53.61 · 2021: $418 · 2022: $654 · 2023: $346 · 2024: $879 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $448.41 | 2023-2024 | Hemosphere |
| Abbott Laboratories | $352.85 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $315.41 | 2019-2025 | Bridion |
| Cumberland Pharmaceuticals, INC. | $234.17 | 2019-2025 | Caldolor |
| Inari Medical, INC. | $193.26 | 2022 | |
| Atricure, INC. | $161.74 | 2024 | |
| Boston Scientific Corporation | $156.18 | 2022-2023 | |
| Abiomed | $133.35 | 2024 | Impella |
| Alexion Pharmaceuticals, INC. | $121.87 | 2022 | |
| Argon Medical Devices, INC. | $100.90 | 2025 | Clot Management |
| Pacira Pharmaceuticals Incorporated | $94.21 | 2022-2023 | Iovera |
| Becton, Dickinson and Company | $75.30 | 2024-2025 | Hemosphere |
| Mindray Ds USA, INC. | $54.01 | 2022-2025 | Te X, Te7 Max |
| Mallinckrodt Enterprises LLC | $52.78 | 2019 | |
| Medtronic, INC. | $47.29 | 2024-2025 | Becker, Shiley |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $44.26 | 2022 | |
| Heron Therapeutics, INC. | $42.01 | 2024 | Aponvie |
| Vyaire Medical, INC. | $38.48 | 2022 | |
| Medtronic Vascular, INC. | $38.39 | 2020 | |
| Covidien LP | $32.24 | 2019 | |
| Masimo Corporation | $31.63 | 2021-2023 | Sedline |
| Csl Behring | $26.16 | 2022 | |
| Ambu INC. | $15.49 | 2021 | |
| Eagle Pharmaceuticals, INC. | $14.53 | 2023 | |
| Fujifilm Sonosite, INC. | $13.40 | 2023 | Sonosite Lx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Mendoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.